Combined modality treatment of laryngeal squamous cell carcinoma.

about

Usefulness of ultrasonography in assessment of laryngeal carcinoma.Smoking status and pain level among head and neck cancer patients Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk.

P2860

Q30429538-1F880BB5-148D-4DD9-96D2-F317A075A8E6 Q33888919-7C687746-91B7-446A-A856-E15D3BA36564 Q34502094-DDD00405-EED0-442D-AFC8-49F6209389A6 Q36963617-D878BB7D-E6D9-4904-B7F9-B4D0B0F57140

P2860

Combined modality treatment of laryngeal squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q36752037

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Combined modality treatment of laryngeal squamous cell carcinoma.

@en

type

Item

label

Combined modality treatment of laryngeal squamous cell carcinoma.

@en

prefLabel

Combined modality treatment of laryngeal squamous cell carcinoma.

@en

P1476

Combined modality treatment of laryngeal squamous cell carcinoma.

@en

P2093

Corey J Langer

http://www.w3.org/2001/XMLSchema#string

John G Devlin

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Cancer statistics, 2006

Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer.

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.

P304

331-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.7.3.331

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17338653

http://www.w3.org/2001/XMLSchema#string

Combined modality treatment of laryngeal squamous cell carcinoma.

about

P2860

P2860

Combined modality treatment of laryngeal squamous cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698